Monopar Therapeutics's dividends per share for the
three
months ended in Mar. 2024 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00. Its Dividend Payout Ratio for the
three
months ended in Mar. 2024 was 0.00. As of today, Monopar Therapeutics's Dividend Yield % is 0.00%.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
For more information regarding to dividend, please check our Dividend Page.
Monopar Therapeutics Dividends per Share Historical Data
The historical data trend for Monopar Therapeutics's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Monopar Therapeutics's Dividends per Share
For the Biotechnology subindustry, Monopar Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Monopar Therapeutics's Dividend Yield % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Monopar Therapeutics's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Monopar Therapeutics's Dividend Yield % falls into.
Monopar Therapeutics Dividends per Share Calculation
Dividends paid to per common share.
Monopar Therapeutics (NAS:MNPR) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Monopar Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monopar Therapeutics Dividends per Share Related Terms
Thank you for viewing the detailed overview of Monopar Therapeutics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Monopar Therapeutics (Monopar Therapeutics) Business Description
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MNPR has been successfully added to your 